These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 8037206)
1. The frequency of the C854 mutation in the aspartoacylase gene in Ashkenazi Jews in Israel. Elpeleg ON; Anikster Y; Barash V; Branski D; Shaag A Am J Hum Genet; 1994 Aug; 55(2):287-8. PubMed ID: 8037206 [TBL] [Abstract][Full Text] [Related]
2. Canavan disease: mutations among Jewish and non-Jewish patients. Kaul R; Gao GP; Aloya M; Balamurugan K; Petrosky A; Michals K; Matalon R Am J Hum Genet; 1994 Jul; 55(1):34-41. PubMed ID: 8023850 [TBL] [Abstract][Full Text] [Related]
3. Identification and expression of eight novel mutations among non-Jewish patients with Canavan disease. Kaul R; Gao GP; Matalon R; Aloya M; Su Q; Jin M; Johnson AB; Schutgens RB; Clarke JT Am J Hum Genet; 1996 Jul; 59(1):95-102. PubMed ID: 8659549 [TBL] [Abstract][Full Text] [Related]
4. Canavan disease: diagnosis and molecular analysis. Matalon R Genet Test; 1997; 1(1):21-5. PubMed ID: 10464621 [TBL] [Abstract][Full Text] [Related]
5. Frequency of a DNA polymorphism at position Y231 in the aspartoacylase gene and its impact on DNA-based carrier testing for Canavan disease in the Ashkenazi Jewish Population. Alford RL; DeMarchi JM; Richards CS Hum Mutat; 1998; Suppl 1():S161-2. PubMed ID: 9452075 [No Abstract] [Full Text] [Related]
6. Canavan disease: carrier-frequency determination in the Ashkenazi Jewish population and development of a novel molecular diagnostic assay. Feigenbaum A; Moore R; Clarke J; Hewson S; Chitayat D; Ray PN; Stockley TL Am J Med Genet A; 2004 Jan; 124A(2):142-7. PubMed ID: 14699612 [TBL] [Abstract][Full Text] [Related]
7. Mutation detection in the aspartoacylase gene in 17 patients with Canavan disease: four new mutations in the non-Jewish population. Sistermans EA; de Coo RF; van Beerendonk HM; Poll-The BT; Kleijer WJ; van Oost BA Eur J Hum Genet; 2000 Jul; 8(7):557-60. PubMed ID: 10909858 [TBL] [Abstract][Full Text] [Related]
8. The molecular basis of canavan (aspartoacylase deficiency) disease in European non-Jewish patients. Shaag A; Anikster Y; Christensen E; Glustein JZ; Fois A; Michelakakis H; Nigro F; Pronicka E; Ribes A; Zabot MT Am J Hum Genet; 1995 Sep; 57(3):572-80. PubMed ID: 7668285 [TBL] [Abstract][Full Text] [Related]
9. Prenatal detection of Canavan disease (aspartoacylase deficiency) by DNA analysis. Elpeleg ON; Shaag A; Anikster Y; Jakobs C J Inherit Metab Dis; 1994; 17(6):664-6. PubMed ID: 7707689 [TBL] [Abstract][Full Text] [Related]
10. The spectrum of mutations of the aspartoacylase gene in Canavan disease in non-Jewish patients. Elpeleg ON; Shaag A J Inherit Metab Dis; 1999 Jun; 22(4):531-4. PubMed ID: 10407784 [TBL] [Abstract][Full Text] [Related]
11. Spongy degeneration of the brain, Canavan disease: biochemical and molecular findings. Matalon RM; Michals-Matalon K Front Biosci; 2000 Mar; 5():D307-11. PubMed ID: 10704428 [TBL] [Abstract][Full Text] [Related]
12. Cloning of the human aspartoacylase cDNA and a common missense mutation in Canavan disease. Kaul R; Gao GP; Balamurugan K; Matalon R Nat Genet; 1993 Oct; 5(2):118-23. PubMed ID: 8252036 [TBL] [Abstract][Full Text] [Related]
13. Identification and characterization of novel mutations of the aspartoacylase gene in non-Jewish patients with Canavan disease. Zeng BJ; Wang ZH; Ribeiro LA; Leone P; De Gasperi R; Kim SJ; Raghavan S; Ong E; Pastores GM; Kolodny EH J Inherit Metab Dis; 2002 Nov; 25(7):557-70. PubMed ID: 12638939 [TBL] [Abstract][Full Text] [Related]